Labeltemplate/use in specific populations: Difference between revisions

Labeltemplate®
Black Box Warning
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Routes and Preparations
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient information
Precautions with Alcohol
Look-Alike Drug Names
Drug Shortage Status
Price

Latest revision as of 14:22, 21 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pregnancy Category (FDA)

Pregnancy Category (AUS)

@@ Line 3: / Line 3: @@
 {{CMG}}
-===[[Labeltemplate dose adjustments#Pregnancy|Pregnancy]]===
+===Pregnancy===
-====[[Pregnancy category#United States|Pregnancy Category (FDA)]]: X====
+: '''[[Pregnancy category#United States|Pregnancy Category (FDA)]]'''
-====[[Pregnancy category#Australia|Pregnancy Category (AUS)]]: X====
+: '''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]'''
-===[[Labeltemplate dose adjustments#Labor and Delivery|Labor and Delivery]]===
+===Labor and Delivery===
-===[[Labeltemplate dose adjustments#Nursing Mothers|Nursing Mothers]]===
+===Nursing Mothers===
-===[[Labeltemplate dose adjustments#Pediatric Use|Pediatric Use]]===
+===Pediatric Use===
-===[[Labeltemplate dose adjustments#Geriatric Use|Geriatric Use]]===
+===Geriatric Use===
-===[[Labeltemplate dose adjustments#Gender|Gender]]===
+===Gender===
-===[[Labeltemplate dose adjustments#Race|Race]]===
+===Race===
-===[[Labeltemplate dose adjustments#Renal Impairment|Renal Impairment]]===
+===Renal Impairment===
-===[[Labeltemplate dose adjustments#Hepatic Impairment|Hepatic Impairment]]===
+===Hepatic Impairment===
-===[[Labeltemplate dose adjustments#Females of Reproductive Potential and Males|Females of Reproductive Potential and Males]]===
+===Females of Reproductive Potential and Males===
-===[[Labeltemplate dose adjustments#Immunocompromised Patients|Immunocompromised Patients]]===
+===Immunocompromised Patients===